AR048671A1 - Procedimiento de vacunacion contra la infeccion testicular por bvdv - Google Patents

Procedimiento de vacunacion contra la infeccion testicular por bvdv

Info

Publication number
AR048671A1
AR048671A1 ARP050100998A ARP050100998A AR048671A1 AR 048671 A1 AR048671 A1 AR 048671A1 AR P050100998 A ARP050100998 A AR P050100998A AR P050100998 A ARP050100998 A AR P050100998A AR 048671 A1 AR048671 A1 AR 048671A1
Authority
AR
Argentina
Prior art keywords
vaccine
bvdv
bvdv type
infection
inactivated
Prior art date
Application number
ARP050100998A
Other languages
English (en)
Inventor
Michael Aaron Ellsworth
Cassius Mcallister P Tucker
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of AR048671A1 publication Critical patent/AR048671A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Procedimiento para tratar o prevenir la infeccion testicular por el virus de la diarrea vírica bovina mediante la inmunizacion de animales macho susceptibles contra la infeccion. Reivindicacion 1: Un procedimiento para prevenir la infeccion testicular por BVDV en un animal macho susceptible que comprende: administrar al animal una cantidad eficaz de una vacuna que se selecciona del grupo que consiste en una vacuna con BVDV tipo 1 inactivado, una vacuna con BVDV tipo 2 inactivado, una vacuna con BVDV tipo 1 vivo modificado y una vacuna BVDV tipo 2 vivo modificado. Reivindicacion 10: El uso de una vacuna que se selecciona del grupo que consiste en una vacuna con BVDV tipo 1 inactivado, una vacuna con BVDV tipo 2 inactivado, una vacuna con BVDV tipo 1 vivo modificado y una vacuna con BVDV tipo 2 vivo modificado para fabricar un medicamento para prevenir la infeccion testicular por BVDV en un animal macho susceptible con riesgo aumentado de infeccion testicular por BVDV.
ARP050100998A 2004-03-17 2005-03-15 Procedimiento de vacunacion contra la infeccion testicular por bvdv AR048671A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55386704P 2004-03-17 2004-03-17

Publications (1)

Publication Number Publication Date
AR048671A1 true AR048671A1 (es) 2006-05-17

Family

ID=34961163

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100998A AR048671A1 (es) 2004-03-17 2005-03-15 Procedimiento de vacunacion contra la infeccion testicular por bvdv

Country Status (23)

Country Link
US (1) US20080260778A1 (es)
EP (1) EP1727562B1 (es)
JP (1) JP4105220B2 (es)
KR (2) KR20060127199A (es)
CN (1) CN1929859A (es)
AR (1) AR048671A1 (es)
AT (1) ATE398462T1 (es)
AU (1) AU2005224179B2 (es)
BR (1) BRPI0508941A (es)
CA (1) CA2560532A1 (es)
DE (1) DE602005007584D1 (es)
DK (1) DK1727562T3 (es)
ES (1) ES2306101T3 (es)
NO (1) NO20063603L (es)
NZ (1) NZ549592A (es)
PL (1) PL1727562T3 (es)
PT (1) PT1727562E (es)
RU (1) RU2335298C2 (es)
SI (1) SI1727562T1 (es)
TW (1) TWI306404B (es)
UA (1) UA86405C2 (es)
WO (1) WO2005089793A1 (es)
ZA (1) ZA200607132B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
WO2012038454A1 (en) * 2010-09-21 2012-03-29 Intervet International B.V. Bvdv vaccine
ES2709190T3 (es) * 2010-12-27 2019-04-15 Elanco Us Inc Composiciones de vacuna contra el virus de la diarrea viral bovina tipo 1B y procedimientos
AR084358A1 (es) 2010-12-27 2013-05-08 Lilly Co Eli Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
US9480739B2 (en) * 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
CN107823639B (zh) * 2017-11-10 2020-10-02 齐鲁动物保健品有限公司 牛病毒性腹泻病毒灭活疫苗及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593873A (en) * 1986-01-27 1997-01-14 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
US5709865A (en) * 1994-11-10 1998-01-20 Biostar Inc. Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6174667B1 (en) * 1997-09-23 2001-01-16 Cornell Research Foundation, Inc. Bovine viral diarrhea virus serum antigen capture
US6606457B2 (en) * 2001-06-19 2003-08-12 Pentax Corporation Focused image tremble correcting device
AU2002356520A1 (en) * 2001-08-09 2003-03-18 Cornell Research Foundation, Inc. Detection of bovine viral diarrhea virus in tissue samples

Also Published As

Publication number Publication date
EP1727562A1 (en) 2006-12-06
JP2007529498A (ja) 2007-10-25
AU2005224179A1 (en) 2005-09-29
SI1727562T1 (sl) 2008-10-31
TWI306404B (en) 2009-02-21
EP1727562B1 (en) 2008-06-18
RU2006133328A (ru) 2008-03-27
TW200531701A (en) 2005-10-01
BRPI0508941A (pt) 2007-08-14
NO20063603L (no) 2006-09-08
AU2005224179B2 (en) 2007-08-23
CA2560532A1 (en) 2005-09-29
CN1929859A (zh) 2007-03-14
WO2005089793A1 (en) 2005-09-29
DE602005007584D1 (de) 2008-07-31
UA86405C2 (ru) 2009-04-27
KR20080036160A (ko) 2008-04-24
US20080260778A1 (en) 2008-10-23
PT1727562E (pt) 2008-09-05
ATE398462T1 (de) 2008-07-15
RU2335298C2 (ru) 2008-10-10
ES2306101T3 (es) 2008-11-01
ZA200607132B (en) 2008-08-27
DK1727562T3 (da) 2008-09-15
JP4105220B2 (ja) 2008-06-25
PL1727562T3 (pl) 2008-10-31
NZ549592A (en) 2008-12-24
KR20060127199A (ko) 2006-12-11

Similar Documents

Publication Publication Date Title
GT200300180A (es) Vacunas para enfermedades reproductoras del ganado
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
ES2118815T3 (es) Virus de la seudorrabia, s-prv-155, atenuado y obtenido por ingenieria genetica y sus usos.
AR054844A1 (es) Vacuna contra lawsonia y metodos de uso de la misma
PA8549701A1 (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
CO6190623A2 (es) Vacuna salmonella
ATE547118T1 (de) Rekombinanter koi-herpesvirus (khv) oder cyprinid-herpesvirus 3 (cyhv-3) und impfstoff zur prävention einer von khv/cyhv-3 bei cyprinus carpio carpio oder cyprinus carpio koi verursachten erkrankung
AR040204A1 (es) Composicion de vacuna meningococica multivalente
AR061930A1 (es) Mimeticuerpos de glp-1 humanos, composiciones, metodos y usos
AR083395A1 (es) Derivado peptidico nmu (neuromedina u) con elevado efecto anorectico
AP2002002568A0 (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals.
AR093185A1 (es) Virus prrs (sindrome reproductivo y respiratorio porcino) que induce al interferon tipo i en celulas susceptibles
ES2570401T3 (es) Métodos de tratamiento usando dosis únicas de oritavancina
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
CO5280138A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para en vacas gestantes
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
PH12020552130A1 (en) Vaccination against porcine circoviruses
AR056017A1 (es) Formulaciones de vacuna animal, metodo para preparar una formulacion de vacuna y componente estabilizador de vacuna
WO2004030614A3 (en) Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
BR0108735A (pt) Proteção in ovo contra bronquite infecciosa
MX2023005182A (es) Parvovirus canino.
MX2009008750A (es) Terapia de vacuna para neovascularizacion coroidal.